BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17880584)

  • 1. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D; Sellheyer K
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
    Sellheyer K; Krahl D
    J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
    Ansai S; Takayama R; Kimura T; Kawana S
    J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms.
    Jimenez FJ; Burchette JL; Grichnik JM; Hitchcock MG
    Mod Pathol; 1995 Oct; 8(8):854-8. PubMed ID: 8552575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichoadenoma of Nikolowski is a distinct neoplasm within the spectrum of follicular tumors.
    Shimanovich I; Krahl D; Rose C
    J Am Acad Dermatol; 2010 Feb; 62(2):277-83. PubMed ID: 20115950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
    Gill P; Naugler C; Abi Daoud MS
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
    Plaza JA; Ortega PF; Stockman DL; Suster S
    J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.